Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation. [electronic resource]
Producer: 19920504Description: 206-16 p. digitalISSN:- 0887-4476
- 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine -- pharmacology
- Animals
- Apomorphine -- pharmacology
- Cerebral Ventricles -- drug effects
- Corpus Striatum -- drug effects
- Denervation
- Desipramine -- pharmacology
- Dopamine -- metabolism
- Electrophysiology -- methods
- Ergolines -- pharmacology
- Injections, Intraventricular
- Iontophoresis
- Male
- Membrane Potentials -- drug effects
- Motor Activity -- drug effects
- Multivariate Analysis
- Neurons -- drug effects
- Oxidopamine -- administration & dosage
- Quinpirole
- Rats
- Rats, Inbred Strains
- Receptors, Dopamine -- drug effects
- Receptors, Dopamine D1
- Receptors, Dopamine D2
- Reference Values
- Substantia Nigra -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.